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This study investigated the association between socioeconomic status (SES) and type 2 
diabetes (T2D) prevalence in Scotland in 2021 and tested the null hypothesis that inequalities 
had not changed since they were last described for 2001-2007. 
Methods 
Data from a national population-based diabetes database for 35-to-84-year-olds in Scotland for 
2021 and mid-year population estimates for 2019 stratified by sex and fifths of the Scottish 
Index of Multiple Deprivation were used to calculate age-specific prevalence of T2D. Age-
standardised prevalence was estimated using the European Standard Population with relative 
risks (RRs) compared between the most (Q1) and least (Q5) deprived fifths for each sex, and 
compared against similar estimates from 2001-2007. 
Results 
Complete data were available for 255,764 people (98.9%) with T2D. Age-standardised 
prevalence was lowest for women in Q5 (3.4%) and highest for men in Q1 (11.6%). RRs have 
increased from 2.00 (95% CI 1.52-2.62) in 2001-2007 to 2.48 (95% CI 2.43-2.53) in 2021 for 
women and from 1.58 (95% CI 1.20-2.07) in 2007 to 1.89 (95% CI 1.86-1.92) in 2021 for men. 
Conclusions 
Socioeconomic inequalities in T2D prevalence have widened between 2001-2007 and 2021. 




What is already known on the subject? 
The association between socioeconomic status and the prevalence of type 2 diabetes is well-
established and the direction and magnitude differs between different countries. A strong 
inverse association between socioeconomic status and type 2 diabetes prevalence was last 
described in Scotland in 2007. Health inequalities in the United Kingdom have generally 
widened in the last decade. 
What this study adds 
Prevalence of type 2 diabetes in Scotland has increased in both sexes, all age groups and 
deprivation quintiles that were investigated, remaining higher in men and older people. Age-
adjusted relative risks for the most compared to the least deprived quintiles for type 2 diabetes 
have increased for men and women between 2007 and 2021. Demands for diabetes care 
continue to increase and effective approaches to primary and secondary prevention of type 2 
diabetes are needed to reduce health inequalities in type 2 diabetes prevalence in Scotland. 
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The inverse association between socioeconomic status (SES) and type 2 diabetes prevalence in 
Scotland was last described using data for 2001-2007 [1]. A 2020 report showed that health 
inequalities in general have increased in the United Kingdom over the past decade [2]. Updated 
estimates of type 2 diabetes prevalence are needed to investigate whether socioeconomic 
inequalities in type 2 diabetes prevalence have changed over time. 
METHODS 
The Scottish Care Information – Diabetes (SCI-Diabetes) database provides population-based 
data for people in Scotland with a diagnosis of diabetes that is made by clinicians on the basis 
of blood glucose or glycated haemoglobin (HbA1c) measurements. It includes extensive 
clinical data that is updated in real time by daily downloads from primary and secondary care 
databases and includes data from all general practices in Scotland. 
An area-based measure of socioeconomic deprivation can be assigned to individuals using their 
postcodes and the Scottish Index of Multiple Deprivation (SIMD). SIMD is based on a 
weighting and combination of 32 indicators across seven domains: income, employment, 
education, health, access to services, crime and housing to produce an index of multiple 
deprivation [3]. Quintiles of the SIMD score can be applied at a national level, with Q1 being 
used to describe the most deprived and Q5 used to describe the least deprived fifths of the 
population respectively. The 2016 version of SIMD was used for this analysis. 
Aggregated data on numbers of people with diabetes for this project were obtained from SCI-
Diabetes for people in Scotland with type 2 diabetes who were alive in February 2021 stratified 
into sex, five-year age groups and SIMD quintile. People who could not be assigned an SIMD 
quintile were excluded. Population data from the National Records of Scotland (NRS) in strata 
of age, sex and SIMD quintile for June 2019 were used as these were the most recently available 
data in the required format [4]. 
Crude prevalence of type 2 diabetes by SIMD and sex was estimated using the numbers of 
people with type 2 diabetes that were alive in February 2021 as the numerators, and population 
estimate as the denominators in five-year age groups.  
The European Standard Population (ESP) for 35- to 84-year-olds was used to estimate the 
directly age-standardised prevalence of type 2 diabetes by sex and SIMD quintiles to control 
potential confounding by age. This age range was chosen to be comparable to that used for 
previous Scottish estimates. Poisson variance calculations were used to calculate standard 
errors for the data. Upper and lower 95% confidence intervals for prevalence were calculated 
by multiplying the standard error by 1.96 and adding or subtracting this number from the age-
standardised prevalence. 
Crude and age-adjusted relative risks were calculated using a ratio for Q1 to Q5 of the crude 
and age-adjusted prevalence of diabetes respectively, separately for men and women. Standard 
errors of the log rate ratios and the delta method were used to calculate 95% confidence 
intervals for these relative risks [5]. 
RESULTS 
Data were available for 255,764 people with type 2 diabetes who were aged between 35 and 
84 years who were alive in February 2021. SIMD could not be assigned for 1,224 women 
(1.11%) and 1,715 men (1.15%).  
Crude prevalence of type 2 diabetes was higher in men than in women across all five quintiles 
of SIMD (p<0.001 chi squared tests for all comparisons) and decreased consistently across 
quintiles from Q1 to Q5 for both men and women (see table 1 that also provides comparable 
data from the 2007 estimates). Overall age-specific prevalence of diabetes by sex in 2021 is 
shown in Figure 1. When further stratified by SIMD quintile age-specific prevalence among 
women varied from 0.5% in Q5 in 35–39-year-old to 17.2% in 80–84-year-olds. In men, age-
specific prevalence varied from 0.8% in Q5 in 35–39-year-olds to 22.4% in Q2 in 75–79-year-
olds. 
Age-standardised prevalence of type 2 diabetes and 95% confidence limits by SIMD quintile 
and sex are shown in Figure 2. Prevalence of type 2 diabetes was higher in men than in women 
across all five quintiles of SES, and there was an inverse association between SES and 
prevalence of type 2 diabetes. The age-standardised prevalence was lower than the crude 
prevalence for all five SES quintiles for both men and women because of the differences in age 
distribution between the Scottish and European standard populations. 
The age-adjusted relative risk for Q1 compared to Q5 was higher in women than it was in men. 
In women the ratio of prevalence of type 2 diabetes between Q1 and Q5 was 2.48 (95% CI 
2.43-2.53), whereas in men it was 1.89 (95% CI 1.86-1.92). This compares to crude relative 
risks for Q1 compared to Q5 of 2.21 (95% CI 2.17-2.25) for women and 1.70 (95% CI 1.67-
1.73) for men. This reflects the younger age on average among Q5 than Q1. 
Table 1: Crude prevalence of type 2 diabetes in Scotland for people aged 35-84 years by 
SIMD quintile and sex for 2007 and 2021 
Year Sex SIMD Quintile RR (95% CI) for 
Q1 vs Q5 1 2 3 4 5 
2007 Men 8.8% 8.0% 7.0% 6.3% 5.4% 1.58 (1.20-2.07) 
Women 7.0% 6.1% 5.1% 4.2% 3.3% 2.00 (1.52-2.62) 
2021 Men 12.6% 11.6% 10.0% 8.6% 7.4% 1.89 (1.86-1.92) 
Women 9.5% 8.4% 6.7% 5.4% 4.3% 2.48 (2.43-2.53) 
 
 
   
  
DISCUSSION 
There is a strong inverse association between socioeconomic status and prevalence of type 2 
diabetes in Scotland, which is more marked in women than in men. Diabetes prevalence 
increases with age and age confounds the association between SES and diabetes prevalence. 
Absolute risk of diabetes was higher in men than women and the relative risk associated with 
deprivation was higher in women than men.  
Crude prevalence of type 2 diabetes has increased between 2007 and 2021 from 7.0% to 9.9% 
in men, and from 5.1% to 6.8% in women. Age-standardised prevalence of type 2 diabetes 
increased for both men and women across all five quintiles of SES in 2021 compared to data 
for 2001-2007. Age-adjusted relative risks for the most deprived to least deprived quintiles 
have increased over time from 2.00 (95% CI 1.52-2.62) in 2007 to 2.48 (95% CI 2.43-2.53) in 
2021 for women, and from 1.58 (95% CI 1.20-2.07) in 2007 to 1.89 (95% CI 1.86-1.92) in 
2021 for men. These findings suggest a widening of socioeconomic inequalities in diabetes 
prevalence, which is more marked in women. 
A strength of this study was the use of data from a population-based diabetes register. Most 
people with a diagnosis of diabetes in Scotland were included, with only 1.1% of those 
excluded due not having SIMD assigned. Calculating age-standardised prevalence was another 
strength as it allowed for confounding by age to be controlled.  
There are some limitations to this study. The most recent population data available were for 
June 2019, whereas the most recent data for type 2 diabetes were from February 2021. This 
may have led to some slight errors when calculating prevalence of type 2 diabetes. The increase 
in the size of the population in Scotland from June 2017 to June 2019 was 1.13%, so these 
errors would not be expected to have had a marked effect on the findings if the population 
changes from 2019 to 2021 were similar. The use of an area-based measure of SES rather than 
an individual one may mean that an individual’s SES is mis-classified. However, the small 
population of 700-800 people included in data zones used to calculate SIMD mitigates this 
limitation. Changes in population distribution by SIMD quintile between 2019 and 2021 could 
also have affected prevalence estimates. It is not clear what effect the wider use of HbA1c to 
diagnose diabetes in recent years may have had on prevalence estimates. 
Other studies from developed countries such as Sweden [6] and Spain [7] found similar 
associations between socioeconomic status and diabetes prevalence, including similar sex 
differences in the strength of the association. The Spanish study found that women living in 
neighbourhoods of SES had a 46% lower prevalence of diabetes compared to women living in 
neighbourhoods in the highest tercile of SES, and men living in neighbourhoods of the highest 
tercile had a 24% lower prevalence of diabetes. This compares to women in the least deprived 
quintile in Scotland in 2021 having a 55% lower prevalence of diabetes than women in the 
most deprived quintile, and men in the least deprived quintile having a 41% lower prevalence 
of diabetes than men in the most deprived quintile. SES was defined differently in these studies 
which means that these studies are not directly comparable, but the patterns are broadly similar. 
In conclusion, there is a clear inverse association between socioeconomic status and prevalence 
of type 2 diabetes, which has grown stronger since the analysis of the 2001-2007 data. Effective 
approaches are required to reduce inequalities in key risk factors for diabetes including obesity. 
It will be important to evaluate the effect on inequalities of interventions to prevent diabetes 
such as those proposed in the Scottish government’s Diabetes Framework for Prevention, Early 
Detection and Early Intervention [8]. A potential area for research would be to try and 
determine which SIMD indicators are the drivers of the health inequalities described in this 
work. Further research is required to describe the medium-term effects of the Covid-19 
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Figure 1 Age-specific prevalence of type 2 diabetes in Scotland 2021 by sex  
Figure 2 Age-standardised prevalence of type 2 diabetes in Scotland 2021 by sex and Scottish 
Index of Multiple Deprivation quintile with 95% confidence limits  
  
 
  
 
